A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study
Schilder, R.J, Sill, M.W, Lankes, H.A, Gold, M.A, Mannel, R.S, Modesitt, S.C, Hanjani, P, Bonebrake, A.J, Sood, A.K, Godwin, A.K, Hu, W, Alpaugh, R.K
Published in Gynecologic oncology (01.04.2013)
Published in Gynecologic oncology (01.04.2013)
Get full text
Journal Article
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
Chase, Dana, Huang, Helen Q, Monk, Bradley J, Ramondetta, Lois Michelle, Penson, Richard T, Gil, Karen, Landrum, Lisa M, Leitao, Mario, Oaknin, Ana, Huh, Warner K, Pulaski, Heather L, Robison, Katina, Guntupalli, Saketh R, Richardson, Debra, Salani, Ritu, Sill, Michael W, Wenzel, Lari B, Tewari, Krishnansu Sujata
Published in International journal of gynecological cancer (01.05.2020)
Published in International journal of gynecological cancer (01.05.2020)
Get full text
Journal Article
LBA26FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE III RANDOMIZED TRIAL OF CHEMOTHERAPY WITH AND WITHOUT BEVACIZUMAB FOR ADVANCED CERVICAL CANCER: A NRG ONCOLOGY - GYNECOLOGIC ONCOLOGY GROUP STUDY
Tewari, K.S., Sill, M.W., Penson, R.T., Huang, H., Ramondetta, L.M., Landrum, L.M., Oaknin, A., Reid, T.J., Leitao, M.M., Monk, B.J., Michael, H.E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Final Overall Survival Analysis of the Phase III Randomized Trial of Chemotherapy with and Without Bevacizumab for Advanced Cervical Cancer: a Nrg Oncology - Gynecologic Oncology Group Study
Tewari, K.S., Sill, M.W., Penson, R.T., Huang, H., Ramondetta, L.M., Landrum, L.M., Oaknin, A., Reid, T.J., Leitao, M.M., Monk, B.J., Michael, H.E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study
Kavanagh, J J, Sill, M W, Ramirez, P T, Warshal, D, Pearl, M L, Morgan, M A
Published in International journal of gynecological cancer (01.05.2008)
Published in International journal of gynecological cancer (01.05.2008)
Get more information
Journal Article